Literature DB >> 26482078

[Antibiotic stewardship: Measures for optimization of antibacterial therapy].

K de With.   

Abstract

Because the development of resistance is steadily increasing, especially among Gram-negative pathogens and new developments in antibiotics are lacking, a rational antibiotic therapy is necessary now more than ever. A continuing uncritical and non-guideline-conform use of antibiotics leads to selection of multidrug-resistant pathogens, which can colonize patients and as instigators of infections make treatment more difficult. A prerequisite for targeted antibiotic therapy is a critical testing of the suspected infection diagnosis based on a guideline-conform microbiological preanalytical procedure. To promote a guideline-conform antibiotic therapy in hospitals with respect to choice of substance, dosage and duration, in December 2013 so-called antibiotic stewardship (ABS) measures were summarized in a so-called S3-guideline from the Association of the Scientific Medical Societies in Germany (AWMF) under the auspices of the German Society for Infectious Diseases (DGI). With a strategy of targeted antibiotic therapy and infection prevention it is possible to achieve optimum treatment results and to minimize the development of resistance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26482078     DOI: 10.1007/s00108-015-3706-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

1.  Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

Authors:  James A McKinnell; Danielle F Kunz; Eric Chamot; Mukesh Patel; Rhett M Shirley; Stephen A Moser; John W Baddley; Peter G Pappas; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-14       Impact factor: 3.254

2.  Postprescription review improves in-hospital antibiotic use: a multicenter randomized controlled trial.

Authors:  P Lesprit; A de Pontfarcy; M Esposito-Farese; H Ferrand; J L Mainardi; M Lafaurie; P Parize; C Rioux; F Tubach; J C Lucet
Journal:  Clin Microbiol Infect       Date:  2014-10-14       Impact factor: 8.067

3.  Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals.

Authors:  Joao B Pereira; Tracey M Farragher; Mary P Tully; Jonathan Jonathan Cooke
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

4.  Prospective audit and feedback in antimicrobial stewardship: is there value in early reviewing within 48 h of antibiotic prescription?

Authors:  Yi Xin Liew; Winnie Lee; Daniel Tay; Sarah Si Lin Tang; Nathalie Grace Sy Chua; Yvonne Zhou; Andrea Lay-Hoon Kwa; Maciej Piotr Chlebicki
Journal:  Int J Antimicrob Agents       Date:  2014-11-25       Impact factor: 5.283

5.  Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes.

Authors:  Houssein Gbaguidi-Haore; Catherine Dumartin; François L'Hériteau; Muriel Péfau; Didier Hocquet; Anne-Marie Rogues; Xavier Bertrand
Journal:  J Antimicrob Chemother       Date:  2012-10-17       Impact factor: 5.790

6.  [Documentation of Antibiotic Stewardship (ABS)-interventions during proactive audit of antibiotic use].

Authors:  Katja Wilke; Katja de With
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2015-10-29

7.  Antibiotic usage in German hospitals: results of the second national prevalence study.

Authors:  Sonja Hansen; Dorit Sohr; Brar Piening; Luis Pena Diaz; Alexander Gropmann; Rasmus Leistner; Elisabeth Meyer; Petra Gastmeier; Michael Behnke
Journal:  J Antimicrob Chemother       Date:  2013-07-19       Impact factor: 5.790

Review 8.  Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-- 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials.

Authors:  Noa Eliakim-Raz; Dafna Yahav; Mical Paul; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2013-05-21       Impact factor: 5.790

9.  Nosocomial infection and antibiotic use: a second national prevalence study in Germany.

Authors:  Michael Behnke; Sonja Hansen; Rasmus Leistner; Luis Alberto Peña Diaz; Alexander Gropmann; Dorit Sohr; Petra Gastmeier; Brar Piening
Journal:  Dtsch Arztebl Int       Date:  2013-09-20       Impact factor: 5.594

10.  A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis.

Authors:  Ting-Shuo Huang; Shie-Shian Huang; Yu-Chiau Shyu; Chun-Hui Lee; Shyh-Chuan Jwo; Pei-Jer Chen; Huang-Yang Chen
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

View more
  1 in total

Review 1.  In vivo and in silico screening for antimicrobial compounds from cyanobacteria.

Authors:  Dorina Strieth; Selina Lenz; Roland Ulber
Journal:  Microbiologyopen       Date:  2022-04       Impact factor: 3.904

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.